Treatment of pediatric patients newly diagnosed with type 1 diabetes with etanercept resulted in lower glycated hemoglobin and increased endogenous insulin production, suggesting the preservation of beta-cell function. This evidence concerns the gene INS and type 1 diabetes mellitus.